| Financial Year |
March 31 2023 |
| Monetary Funds |
385,120,747.81 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
165,252,162.93 |
| Accounts Receivable |
305,407,072.23 |
| Advances to Suppliers |
11,436,070.51 |
| Other Receivables |
11,809,165.81 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
115,039,929.55 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
53,553,441.29 |
| Other Current Assets |
35,590,360.60 |
| Total Current Assets |
1,231,933,246.44 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
18,426,798.67 |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
502,325,375.88 |
| Under-construction Projects |
9,781,647.43 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
385,816,544.44 |
| R&D expenses |
-- |
| Goodwill |
50,277,614.44 |
| Long-Term Deferred and Prepaid Expenses |
7,286,538.31 |
| Deferred Income Tax Assets |
70,477,052.03 |
| Other Non-Current Assets |
492,568,008.92 |
| Sub-Total of Non-Current Assets |
1,700,457,383.63 |
| Total Assets |
2,932,390,630.07 |
| Short-Term Loans |
299,473,714.32 |
| Trading Financial liabilities |
-- |
| Notes Payable |
303,852,421.24 |
| Accounts Payable |
329,628,865.77 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
6,816,410.32 |
| Taxes Payable |
10,875,641.54 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
47,354,205.85 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
47,696,323.95 |
| Other Current Liabilities |
11,789,040.78 |
| Sub-Total of Current Liabilities |
1,079,485,302.13 |
| Long-term Loans |
191,486,444.60 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,139,484.50 |
| Deferred Income Tax Liabilities |
5,525,416.98 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
228,823,976.87 |
| Total Liabilities |
1,308,309,279.00 |
| Paid-In Capital(Or Share Stock) |
259,063,097.00 |
| Capital Surplus |
1,146,548,984.09 |
| Surplus Reserve |
58,095,545.39 |
| LESS:Treasury Stock |
15,006,201.00 |
| Undistributed Profits |
155,452,086.98 |
| Minority Stockholder's Interest |
14,254,350.09 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,609,827,000.98 |
| Owner's Equity（Stockholder's Equity） |
1,624,081,351.07 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,932,390,630.07 |
